Doximity, Inc. (DOCS) News
Filter DOCS News Items
DOCS News Results
|Loading, please wait...|
DOCS News Highlights
- For DOCS, its 30 day story count is now at 65.
- Over the past 17 days, the trend for DOCS's stories per day has been choppy and unclear. It has oscillated between 1 and 14.
- ROSE, PAY and GDS are the most mentioned tickers in articles about DOCS.
Latest DOCS News From Around the Web
Below are the latest news stories about DOXIMITY INC that investors may wish to consider to help them evaluate DOCS as an investment opportunity.
Doximity has seen its revenue growth rates stabilize, while it remains highly profitable. Click here to find out why DOCS is a Buy.
The stock still trades at close to 50 times earnings.
Ever since Doximity (NYSE: DOCS) went public in June 2021, the stock has been commanding a significant premium. Unsurprisingly, as investors have become more focused on valuations and earnings multiples, shares of Doximity have been falling in value and are down 38% year to date. Investors may be wondering if this has created a buying opportunity for a business that still sees plenty of growth in its future.
Doximity Inc. (NYSE:DOCS) closed Monday at $31.16 per share, down from $31.70 a day earlier. While Doximity Inc. has underperformed by -1.70%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DOCS fell by -49.09%, with highs and lows ranging from $68.94 to $22.91, whereas the simple […]
The online platform for physicians could 10x over the next 10 years.
A topsy-turvy stock market isn't going to knock these growth stocks off of their upward-sloping paths forward.
Most investors would answer yes, but that doesn't mean we can afford to go all in on the most popular growth stocks of the day. Fiverr International (NYSE: FVRR) was a stock market darling in the early days of the COVID-19 pandemic. Fiverr is an important member of the growing gig economy.
The digital platform for doctors has always focused on profitable growth, and it''s really starting to pay off.
The digital platform for doctors has always focused on profitable growth, and it's really starting to pay off.
The share price of Doximity Inc. (NYSE:DOCS) rose to $32.78 per share on Tuesday from $30.95. While Doximity Inc. has overperformed by 5.91%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, DOCS fell by -53.68%, with highs and lows ranging from $72.60 to $22.91, whereas the […]